|
시장보고서
상품코드
2050789
수의 종양학 시장 : 동물 유형별, 치료법별, 투여 경로별, 용도별, 유통 채널별, 지역별Veterinary Oncology Market, By Animal Type, By Therapy Type, By Mode of Administration, By Application, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
수의 종양학 시장은 2026년에 9억 780만 달러로 추정되고 있으며, 2033년까지 20억 680만 달러에 달할 것으로 전망되고 있습니다. 2026-2033년에는 CAGR 12.0%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 9억 780만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.00% | 2033년 시장 규모 예측 : | 20억 680만 달러 |
동물 의료 비용의 증가와 반려동물 사육두수 증가로 인해 수의종양학 시장은 괄목할 만한 성장세를 보이고 있습니다. 사람과 동물의 유대감이 깊어지고 반려동물의 암에 대한 인식이 높아지면서 수의종양학 분야의 첨단 진단 및 치료법에 대한 수요가 증가하고 있습니다. 또한 개와 고양이의 림프종, 유선종양, 구강흑색종, 비만세포종 등의 암 발생률이 증가함에 따라 효과적인 치료 옵션과 조기 발견의 필요성이 높아지고 있습니다. 수의 종양 전문의와 종양학 전문가의 증가와 더불어 혁신적인 약물 개발을 위한 지속적인 연구가 글로벌 시장 확대를 더욱 촉진하고 있습니다. 그러나 암 치료 및 진단 절차에 따른 고비용은 여전히 큰 문제점으로 남아있습니다.
시장 역학
세계의 수의종양학 시장의 성장은 반려동물의 암 발생률 증가, 반려동물 보험 가입 증가, 동물 의료비 증가, 기술 발전 등에 의해 주도되고 있습니다. 통계에 따르면 10세 이상 개의 50% 이상이 암에 걸리며, 림프종은 개에서 가장 흔한 혈액암입니다. 급속한 도시화에 따른 핵가족화, 고독감 증가로 인해 전 세계에서 반려동물을 키우는 비율이 높아지고 있습니다. 이에 따라 반려동물 보호자들은 반려동물의 건강에 대한 인식이 높아졌고, 보다 질 높은 치료를 위해 더 많은 비용을 지출하는 경향이 강해지고 있습니다. 다양한 기관들이 수의종양학 관련 임상 시험 및 연구 활동을 재정적으로 지원하고 있으며, 이는 시장 성장에 중요한 역할을 하고 있습니다. 그러나 항암제, 진단 검사, 수술에 따른 높은 비용과 개발도상국에서의 낮은 인지도는 예측 기간 중 시장 확대를 저해할 것으로 예상됩니다. 소셜미디어 캠페인과 컨퍼런스를 통해 반려동물 암에 대한 인식을 높이기 위한 지속적인 노력은 시장의 주요 플레이어들에게 많은 수익성 있는 기회를 제공할 것으로 기대됩니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적 매출 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계의 수의학 종양학 시장의 주요 기업을 프로파일링합니다. : 회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략.
- 본 조사에서 다루어지고 있는 주요 기업에는 Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, Regeneus Ltd.가 포함됩니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 돕습니다.
- 세계의 수의학 종양학 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 수의종양학 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 원활하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 수의 종양학 시장 : 동물 유형별, 2021-2033년
제5장 세계의 수의 종양학 시장 : 요법 유형별, 2021-2033년
제6장 세계의 수의 종양학 시장 : 투여 방법별, 2021-2033년
제7장 세계의 수의 종양학 시장 : 용도별, 2021-2033년
제8장 세계의 수의 종양학 시장 : 유통 채널별, 2021-2033년
제9장 세계의 수의 종양학 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 제안
제12장 참고 문헌 및 조사 방법
KSA 26.06.10Veterinary Oncology Market is estimated to be valued at USD 907.8 Mn in 2026 and is expected to reach USD 2,006.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 907.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.00% | 2033 Value Projection: | USD 2,006.8 Mn |
The veterinary oncology market is experiencing significant growth due to rising animal healthcare expenditure and increasing pet ownership. Growing human-animal bonds and rising awareness about cancer in companion animals are propelling demand for advanced diagnostic methods and therapeutic procedures for veterinary oncology. Moreover, increasing incidence of cancers such as lymphoma, mammary tumor, oral melanoma, and mast cell tumors in dogs and cats is driving the need for effective treatment options and early detection. Growing number of veterinary oncologists and oncology specialists along with ongoing research for developing innovative drug formulations are further supporting market expansion on a global level. However, high costs associated with cancer therapies and diagnostic procedures remain a major challenge.
Market Dynamics
The global veterinary oncology market growth is driven by rising incidence of cancer in companion animals, increase in pet insurance purchases, growing animal health expenditure, and technological advancements. According to statistics, over 50% of dogs over the age of 10 will develop cancer and lymphoma is the most common blood cancer in dogs. Rapid urbanization accompanied with rising nuclear families and increasing loneliness levels have boosted pet adoption rates globally. This has led to pet owners becoming more aware regarding the health of their pets and willing to spend more on premium treatments. Various organizations are financially supporting clinical trials and research activities related to veterinary oncology which is playing a significant role in market growth. However, high costs associated with oncology medications, diagnostic tests, surgeries, and lack of awareness in developing nations are anticipated to hamper the market expansion during the forecast period. Ongoing initiatives to spread awareness regarding cancer in pets through social media campaigns and conferences are expected to bring numerous lucrative opportunities for key players in the market.
Key Features of the Study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global veterinary oncology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Zoetis Inc., Elanco, AB Science, Boehringer Ingelheim International GmbH, Zenoaq, VetDC, Morphogenesis, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., AdvaVet, Inc., Rhizen Pharmaceutical SA., PetCure Oncology, Varian Medical Systems, Accuray Incorporated, One Health, and Regeneus Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global veterinary oncology market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global veterinary oncology market.
Market Segmentation
- By Animal Type (Revenue, USD Mn, 2021 - 2033)
- Companion Animal
- Equine
- Canine
- Feline
- Livestock Animal
- By Therapy Type (Revenue, USD Mn, 2021 - 2033)
- Chemotherapy
- Combination Therapy
- Immunotherapy
- Targeted Therapy
- By Mode of Administration (Revenue, USD Mn, 2021 - 2033)
- Oral
- Intravenous
- By Application (Revenue, USD Mn, 2021 - 2033)
- Canine Lymphoma
- Osteosarcoma (OSA)
- Mast Cell Cancer
- Melanoma
- Others
- By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Government Agencies
- Retail Pharmacies
- By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Zoetis Inc.
- Elanco
- AB Science
- Boehringer Ingelheim International GmbH
- Zenoaq
- VetDC
- Morphogenesis, Inc.
- Karyopharm Therapeutics, Inc.
- Regeneus Ltd.
- AdvaVet, Inc.
- Rhizen Pharmaceutical SA.
- PetCure Oncology
- Varian Medical Systems
- Accuray Incorporated
- Merck Animal Health
- VolitionRx Limited
- Regeneus Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Animal Type
- Market Snapshot, By Therapy Type
- Market Snapshot, By Mode of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Epidemiology
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Veterinary Oncology Market, By Animal Type, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Companion Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Equine
- Canine
- Feline
- Livestock Animal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Veterinary Oncology Market, By Therapy Type, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Chemotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Combination Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Immunotherapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Targeted Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Veterinary Oncology Market, By Mode of Administration, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Veterinary Oncology Market, By Application, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Canine Lymphoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Osteosarcoma (OSA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Mast Cell Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Melanoma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Veterinary Oncology Market, By Distribution Channel, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Government Agencies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Veterinary Oncology Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Animal Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Zoetis Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Elanco
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AB Science
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zenoaq
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- VetDC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Morphogenesis, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Karyopharm Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneus Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AdvaVet, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Rhizen Pharmaceutical SA.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PetCure Oncology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Varian Medical Systems
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Accuray Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck Animal Health
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Regeneus Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- VolitionRx Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zoetis Inc.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
